Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,599 | -48,740 | -35,090 | -26,791 | -179,053 |
| Depreciation Amortization | 309 | 232 | 155 | 78 | 318 |
| Accounts receivable | -60 | 68 | -741 | -307 | 177 |
| Other Working Capital | -5,723 | -2,247 | -1,001 | 4,345 | 2,306 |
| Other Operating Activity | -6,954 | -6,531 | -4,203 | 4,969 | 21,246 |
| Operating Cash Flow | $-72,027 | $-57,218 | $-40,880 | $-17,706 | $-155,006 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -20 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 39,688 | 32,687 | 32,219 | 26,743 | 27,540 |
| Other Financing Activity | -528 | -303 | -289 | -117 | -1,018 |
| Financing Cash Flow | $36,660 | $32,384 | $31,930 | $26,626 | $26,522 |
| Beginning Cash Position | 65,221 | 65,221 | 65,221 | 65,221 | 193,725 |
| End Cash Position | 29,854 | 40,387 | 56,271 | 74,141 | 65,221 |
| Net Cash Flow | $-35,367 | $-24,834 | $-8,950 | $8,920 | $-128,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,027 | -57,218 | -40,880 | -17,706 | -155,006 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -20 |
| Free Cash Flow | -72,027 | -57,218 | -40,880 | -17,706 | -155,026 |